文献速递糖尿病肥胖与代谢综合征

通过体重管理降低血糖(GLoW):一项随机对照试验,比较糖尿病教育与行为体重管理项目对比糖尿病教育项目在新诊断2型糖尿病成人中的临床与成本效果

Glucose Lowering through Weight management (GLoW): a randomised controlled trial of the clinical and cost effectiveness of a diabetes education and behavioural weight management programme vs a diabetes education programme in adults with a recent diagnosis of type 2 diabetes.
PubMed 文献 · Diabetologia · 2025-01-23

该试验在英格兰159家初级保健机构招募577例新诊断(≤3年)超重或肥胖的2型糖尿病成人,随机分入远程定制糖尿病教育联合商业行为体重管理项目(DEW)组或标准糖尿病教育(DE)组。12个月时HbA1c变化两组无显著差异,DEW组体重降低更多且糖尿病缓解率更高(12个月RR 2.53),并具成本效果。

要点

  • 12个月HbA1c变化两组差异无统计学意义(差异-0.84 mmol/mol,95%CI -2.99至1.31,p=0.44)。
  • DEW组体重在6个月和12个月均较DE组降低(分别-1.77 kg和-1.38 kg)。
  • DEW组12个月糖尿病缓解可能性高于DE组(RR 2.53,95%CI 1.30至5.16)。

核心结论

  • 在2型糖尿病诊断后,商业行为体重管理项目联合远程饮食咨询未能在干预后12个月内改善HbA1c。
  • 该干预可帮助实现体重减轻,且与当前国家卫生服务体系标准照护相比具有成本效果。

研究设计与样本

  • 实用型随机平行两组试验,在英格兰159家初级保健机构招募成人(≥18岁)超重或肥胖(BMI≥25 kg/m2)且新诊断(≤3年)2型糖尿病者。
  • 随机分为定制糖尿病教育和行为体重管理项目(DEW;由Weight Watchers实施)组或当前标准糖尿病教育(DE;DESMOND项目)组,采用计算机生成随机序列按1:1分配,按性别和糖尿病病程分层,收集和分析数据者不知分组。
  • 因干预性质参与者无法设盲;共随机577例(DEW组289例,DE组288例),398例(69%)完成12个月随访;评估在0、6、12个月进行。

主要发现

  • HbA1c从基线至12个月变化:组间差异-0.84 mmol/mol(95%CI -2.99至1.31,p=0.44),无干预效应证据;6个月差异-1.83 mmol/mol(95%CI -4.05至0.40)。
  • 体重:6个月组间差异-1.77 kg(95%CI -2.86至-0.67),12个月-1.38 kg(95%CI -2.56至-0.19),存在干预效应。
  • 糖尿病缓解:DEW组较DE组6个月RR 2.10(95%CI 1.03至4.47),12个月RR 2.53(95%CI 1.30至5.16)。
  • 成本效果:DEW较DE在试验内和终身分析中均具成本效果,终身分析增量成本效果比为每获得一个质量调整生命年2290英镑。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 因干预性质参与者无法设盲。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

AIMS/HYPOTHESIS: UK standard care for type 2 diabetes is structured diabetes education, with no effects on HbA1c, small, short-term effects on weight and low uptake. We evaluated whether remotely delivered tailored diabetes education combined with commercial behavioural weight management is cost-effective compared with current standard care in helping people with type 2 diabetes to lower their blood glucose, lose weight, achieve remission and improve cardiovascular risk factors. METHODS: We conducted a pragmatic, randomised, parallel two-group trial. Participants were adults (≥18 years) with overweight or obesity (BMI≥25 kg/m2) and recently diagnosed with type 2 diabetes (≤3 years), recruited from 159 primary care practices in England. We randomised participants to a tailored diabetes education and behavioural weight management programme (DEW; delivered by Weight Watchers) or to current standard care diabetes education (DE; Diabetes Education and Self Management for Ongoing and Newly Diagnosed [DESMOND] programme), using a computer-generated randomisation sequence in a 1:1 allocation stratified by gender and diabetes duration, unknown to those collecting and analysing the data. Participants could not be blinded due to the nature of the interventions. Participants completed assessments at 0, 6 and 12 months. The primary outcome was 12 month change from baseline in HbA1c. We also assessed bodyweight, blood pressure, cholesterol (total, HDL, LDL), glucose-lowering medication, behavioural measures (physical activity, food intake), psychosocial measures (eating behaviour, diabetes-related quality of life, wellbeing) and within-trial and modelled lifetime cost effectiveness. RESULTS: We randomised 577 participants (DEW: 289, DE: 288); 398 (69%) completed 12 month follow-up. We found no evidence for an intervention effect on change in HbA1c from baseline to 12 months (difference: -0.84 [95% CI -2.99, 1.31] mmol/mol, p=0.44) or 6 months (-1.83 [-4.05, 0.40] mmol/mol). We found an intervention effect on weight at 6 (-1.77 [-2.86, -0.67] kg) and 12 months (-1.38 [-2.56, -0.19] kg). Participants in DEW had a higher likelihood of achieving diabetes remission than participants in DE (6 months: RR 2.10 [95% CI 1.03, 4.47]; 12 months: RR 2.53 [1.30, 5.16]). DEW was cost-effective compared with DE in within-trial and lifetime analyses, in the latter generating an incremental cost effectiveness ratio of £2290 per quality-adjusted life year gained. CONCLUSIONS/INTERPRETATION: A commercial behavioural weight management programme combined with remote dietary counselling after diagnosis of type 2 diabetes did not improve HbA1c up to 12 months post intervention in this trial. The intervention could help people achieve weight loss and be cost-effective compared with current standard National Health Service care. TRIAL REGISTRATION: ISRCTN 18399564 FUNDING: National Institute for Health and Care Research (NIHR; RP-PG-0216-20010), Medical Research Council (MC_UU_00006/6), NIHR Cambridge Biomedical Research Centre (NIHR203312).

来源:Diabetologia,查看原文。版权归原作者所有。

引用

  1. Mueller J, Breeze P, Fusco F, et al. Glucose Lowering through Weight management (GLoW): a randomised controlled trial of the clinical and cost effectiveness of a diabetes education and behavioural weight management programme vs a diabetes education programme in adults with a recent diagnosis of type 2 diabetes. Diabetologia. 2025. PMID: 39849151. doi:10.1007/s00125-024-06355-6

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。